Conventional papillary thyroid carcinoma with intraglandular lymphatic dissemination shows more aggressive features
- PMID: 35863013
- DOI: 10.1093/jjco/hyac119
Conventional papillary thyroid carcinoma with intraglandular lymphatic dissemination shows more aggressive features
Abstract
Objective: To investigate the invasive capability and other clinicopathological features of conventional papillary thyroid carcinoma (CVPTC) with intraglandular lymphatic dissemination.
Methods: Seventy-three conventional papillary thyroid carcinoma patients receiving total thyroidectomy were analyzed in this study. The expression of BRAF-V600E, D2-40 and CD31 in all thyroid samples was detected by immunohistochemical staining. The results were evaluated by two pathologists and were statistically analyzed. The rate of positive BRAF-V600E expression and the clinical invasiveness of CVPTC with intraglandular dissemination, multifocal non-intraglandular dissemination-CVPTC and single focus-CVPTC were evaluated. The correlation between BRAF-V600E expression, lymphatic vessel density, microvessel density and the clinicopathological characteristics of conventional papillary thyroid carcinoma were assessed.
Results: Twenty-five intraglandular dissemination-CVPTC, 17 multifocal non-intraglandular dissemination-CVPTC and 31 single focus-CVPTC cases were included in this study. The results showed that BRAF-V600E expression was independently correlated with intraglandular dissemination, age and pN staging (P < 0.05). The lymphatic vessel density in the intraglandular dissemination-CVPTC group was higher than that in the non-intraglandular dissemination-CVPTC group (P < 0.05). Compared with cases without intraglandular dissemination, intraglandular dissemination-CVPTC was associated with a younger age, higher lymph node metastasis rate, pN staging, the expression of BRAF-V600E and increased Capsule invasion and lymphovascular tumor thrombus (P < 0.05). During the follow-up of 30 months (median 15 months), two patients in the intraglandular dissemination-CVPTC group had cervical lymph node metastasis after the first operation.
Conclusions: Intraglandular dissemination-CVPTC shows more aggressive features, and intraglandular lymphatic dissemination may be a potential biological indicator of poor prognosis.
Keywords: biological behavior; intraglandular dissemination; morphological characteristics; multifocal; thyroid cancer.
© The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Intraglandular dissemination: a special pathological feature.Front Oncol. 2024 Jul 29;14:1428274. doi: 10.3389/fonc.2024.1428274. eCollection 2024. Front Oncol. 2024. PMID: 39135992 Free PMC article. Review.
-
Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4072-e4083. doi: 10.1210/clinem/dgab396. J Clin Endocrinol Metab. 2021. PMID: 34231847
-
[Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].Zhonghua Zhong Liu Za Zhi. 2017 May 23;39(5):361-366. doi: 10.3760/cma.j.issn.0253-3766.2017.05.008. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28535653 Chinese.
-
Correlation between the BRAF V600E mutation status and the clinicopathologic features of papillary thyroid carcinoma.Genet Mol Res. 2015 Jul 3;14(3):7377-85. doi: 10.4238/2015.July.3.13. Genet Mol Res. 2015. PMID: 26214416
-
BRAF(V600E) mutation in Turkish patients with papillary thyroid cancer: strong correlation with indicators of tumor aggressiveness.Endocrine. 2012 Oct;42(2):404-10. doi: 10.1007/s12020-012-9651-x. Epub 2012 Mar 17. Endocrine. 2012. PMID: 22426956
Cited by
-
Intraglandular dissemination: a special pathological feature.Front Oncol. 2024 Jul 29;14:1428274. doi: 10.3389/fonc.2024.1428274. eCollection 2024. Front Oncol. 2024. PMID: 39135992 Free PMC article. Review.
-
Construction and validation of nomograms to predict central lymph node metastasis in clinical node-negative unilateral papillary thyroid carcinoma.Sci Rep. 2025 Jan 21;15(1):2662. doi: 10.1038/s41598-025-86201-w. Sci Rep. 2025. PMID: 39837926 Free PMC article.
-
SERPINA1 methylation as a novel diagnostic marker for early-stage papillary thyroid carcinoma via MAPK6-AKT/mTOR pathway.Clin Epigenetics. 2025 May 29;17(1):86. doi: 10.1186/s13148-025-01891-3. Clin Epigenetics. 2025. PMID: 40442821 Free PMC article.
-
Unifocal Conventional Papillary Thyroid Carcinoma with Coexisting Caseating Granulomatous Inflammation in India.Indian J Otolaryngol Head Neck Surg. 2025 Jan;77(1):477-481. doi: 10.1007/s12070-024-05137-1. Epub 2024 Oct 22. Indian J Otolaryngol Head Neck Surg. 2025. PMID: 40070997
-
The Prognostic Role of Lymphatic Vessel Density in Papillary Thyroid Carcinoma: A Systematic Review and Meta-analysis.Cancer Diagn Progn. 2025 Sep 1;5(5):542-551. doi: 10.21873/cdp.10468. eCollection 2025 Sep-Oct. Cancer Diagn Progn. 2025. PMID: 40900891 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials